28-Jan-2026
Download PDF
Shilpa Medicare
Press release of Shilpa Biologicals Pvt Ltd a material subsidiary of Shilpa Medicare Limited. and mAb Tree Biologicals on achieving a Major U.S. FDA Milestone as Flagship Breakthrough Biologic secures orphan drug designation for rare blood cancers.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
